GoldmanSachs International Form 38.5a - UDG Healthcare plc - Amendment (6666I)

TIDMUDG

RNS Number : 6666I

GoldmanSachs International

13 August 2021

Amendment - due to the amendment of Derivative transactions, the disclosure made on 12 July for dealings on 11 July has been updated. Section 2(b) has been updated.

FORM 38.5(a)

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

1. KEY INFORMATION

 
 Name of exempt principal trader            (GS) GOLDMAN SACHS INTERNATIONAL 
 Company dealt in                                  UDG HEALTHCARE PLC 
                                           --------------------------------- 
 Class of relevant security to which the        EUR 0.05 ordinary shares 
  dealings being disclosed relate (Note1) 
                                           --------------------------------- 
 Date of dealing                                     11 August 2021 
                                           --------------------------------- 
 
   2.    DEALINGS (Note 2) 

(a) Purchases and sales

 
 Total number of relevant securities acquired   Highest price paid (Note   Lowest price paid (Note 
                                                           3)                         3) 
                   205,952                            10.7900 GBP                10.7750 GBP 
                                               -------------------------  ------------------------ 
 
 
 Total number of relevant securities   Highest price received   Lowest price received 
  disposed                                    (Note 3)                 (Note 3) 
                7,997                       10.7850 GBP              10.7750 GBP 
                                      -----------------------  ---------------------- 
 

(b) Derivatives transactions (other than options transactions)

 
 Product name, e.g.      Nature of transaction      Number of relevant securities   Price per unit 
  CFD                           (Note 4)                       (Note 5)                (Note 3) 
        CFD           Increasing a short position              80,304                10.7825 GBP 
                     ----------------------------  ------------------------------  --------------- 
        CFD            Reducing a short position                7,682                10.7840 GBP 
                     ----------------------------  ------------------------------  --------------- 
        CFD           Increasing a short position              125,000               10.7859 GBP 
                     ----------------------------  ------------------------------  --------------- 
 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

 
 Product name,e.g.   Writing, selling,       Number of        Exercise       Type, e.g.       Expiry    Option money 
  call option           purchasing,          securities         price    American, European    date     paid/received 
                          varying           to which the                        etc.                    per unit (Note 
                           etc.                option                                                         3) 
                                          relates (Note 5) 
 
 
   (ii)            Exercising 
 
 Product name,e.g. call option   Number of securities   Exercise price per unit (Note 
                                                                      3) 
 
 

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

 
 Full details of any agreement, arrangement or understanding between the person disclosing 
  and any other person relating to the voting rights of any relevant securities under 
  any option referred to on this form or relating to the voting rights or future acquisition 
  or disposal of any relevant securities to which any derivative referred to on this 
  form is referenced. If none, this should be stated. 
                                            NONE 
 
 
 Date of disclosure                                         13 August 2021 
 Contact name                                       Paul Grainger and Kashif Rafiq 
                                                -------------------------------------- 
 Telephone number                                [phone] / [phone] 
                                                -------------------------------------- 
 Name of offeree/offeror with which connected             UDG HEALTHCARE PLC 
                                                -------------------------------------- 
 Nature of connection (Note 6)                            Advisor to Offeree 
                                                -------------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEDKNBNOBKDBFD

(END) Dow Jones Newswires

August 16, 2021 02:00 ET (06:00 GMT)